2025-01-26 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Review

**1. Performance Comparison & Divergence:**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of products and services.  Over the period analyzed, UNH's cumulative return (145.62%) significantly outperformed the S&P 500's (VOO) cumulative return (122.16%). The difference is 23.5%, placing it in the 90th percentile (19.8% on a relative scale) of its historical performance relative to the S&P 500.  This suggests UNH has historically shown a tendency to outperform the broader market.

The provided Alpha and Beta analysis reveals consistently positive Alpha (ranging from 0.1 to 0.1), demonstrating consistent outperformance relative to the market benchmark. The Beta, while fluctuating, generally remains high (1.8 to 1.82), indicating higher sensitivity to market movements than average.  However, the recent negative CAGR (-24% and -9% for 2022-2024 and 2023-2025 respectively) is concerning and warrants further investigation.


**2. Recent Price Movement:**

* **Closing Price:** $532.51
* **5-day Moving Average:** $523.35
* **20-day Moving Average:** $519.36
* **60-day Moving Average:** $552.21

The closing price is above the 5-day and 20-day moving averages, suggesting short-term upward momentum. However, it's below the 60-day moving average, indicating a potential short-term correction from a higher point. The recent price change of $0.52 reflects a minor daily increase, not a significant jump.


**3. Technical Indicators & Expected Return:**

* **RSI:** 62.26 – Slightly above the neutral level of 50, suggesting neither overbought nor oversold conditions.
* **PPO:** 0.5984 – A positive value indicates bullish momentum.
* **Relative Strength (20-day):**  A positive change of 3.1 points indicates short-term upward momentum.
* **Expected Return:** 321.7% – This exceptionally high projected return over the long term (2+ years) relative to the S&P 500 needs careful consideration.  It's crucial to understand the assumptions and model used to arrive at this figure.  Such a high return suggests significant upside potential but is also inherently uncertain.

**4. Recent Earnings Analysis:**

The provided earnings data shows some volatility. While Q3 and Q4 2024 show strong EPS growth, Q2 2024 experienced a significant EPS decline, and there is a discrepancy and duplication in the data for November 4, 2024.  A thorough review of the data source is necessary to ensure accuracy. Revenue remains relatively consistent, demonstrating a strong and stable business base.  Further investigation is needed to explain the sharp EPS drop in Q2 2024.


**5. Financial Information Analysis:**

The financial data reveals strong and mostly consistent revenue growth. Profit margins have remained fairly stable around 21-24%, demonstrating healthy profitability.  Equity shows moderate growth, however, the ROE displays significant volatility, with a negative figure in Q1 2024. This needs further investigation to understand the underlying causes.  Overall, while revenue is strong, the fluctuations in ROE warrant a closer examination of the company's capital allocation strategy and profitability drivers.


**7. Overall Analysis:**

UNH has historically outperformed the S&P 500, displaying strong revenue and generally healthy profit margins. However, recent performance data (particularly the sharp negative CAGRs in 2022-2024 and 2023-2025, the volatile ROE, and inconsistent EPS) raises some concerns. The extraordinarily high projected long-term return should be treated with skepticism unless a thorough understanding of its basis is provided.  Further investigation into the causes of the recent volatility in EPS and ROE is crucial before making investment decisions.  The short-term price action suggests potential for further upward movement, but this needs to be considered alongside the longer-term uncertainties.  A thorough analysis of the company's future prospects, considering macroeconomic factors and competitive landscape, is necessary to determine the true investment potential.

**8. Disclaimer:** This analysis is based solely on the provided data and should not be considered investment advice.  Independent research and consultation with a financial advisor are strongly recommended before making any investment decisions.  The accuracy of the provided data should be independently verified.
